The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole
Abstract Background Fluconazole (FLC) is a widely used antifungal agent; however, Candida albicans is increasingly developing resistance to it. Given the limited range of available antifungal drugs, there is an immediate requirement for the development of novel approaches to improve FLC efficacy aga...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2026-01-01
|
| Sraith: | BMC Microbiology |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12866-025-04701-1 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|